<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:11:00Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10405135" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10405135</identifier>
        <datestamp>2023-08-08</datestamp>
        <setSpec>ehjqcco</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Eur Heart J Qual Care Clin Outcomes</journal-id>
              <journal-id journal-id-type="iso-abbrev">Eur Heart J Qual Care Clin Outcomes</journal-id>
              <journal-id journal-id-type="publisher-id">ehjqcco</journal-id>
              <journal-title-group>
                <journal-title>European Heart Journal. Quality of Care &amp; Clinical Outcomes</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">2058-5225</issn>
              <issn pub-type="epub">2058-1742</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10405135</article-id>
              <article-id pub-id-type="pmcid">PMC10405135</article-id>
              <article-id pub-id-type="pmc-uid">10405135</article-id>
              <article-id pub-id-type="pmid">37451698</article-id>
              <article-id pub-id-type="pmid">37451698</article-id>
              <article-id pub-id-type="doi">10.1093/ehjqcco/qcad040</article-id>
              <article-id pub-id-type="publisher-id">qcad040</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Cohort Profile</subject>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00200</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Cohort profile: Evaluation of the Methods and Management of Acute Coronary
Events (EMMACE) longitudinal cohort</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1307-6691</contrib-id>
                  <name>
                    <surname>Munyombwe</surname>
                    <given-names>Theresa</given-names>
                  </name>
                  <!--T.munyombwe@leeds.ac.uk-->
                  <aff><institution>Leeds Institute of Cardiovascular and Metabolic Medicine, University of
Leeds</institution>, <addr-line>6 Clarendon Way, LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <xref rid="cor1" ref-type="corresp"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dondo</surname>
                    <given-names>Tatendashe B</given-names>
                  </name>
                  <aff><institution>Leeds Institute of Cardiovascular and Metabolic Medicine, University of
Leeds</institution>, <addr-line>6 Clarendon Way, LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hall</surname>
                    <given-names>Marlous</given-names>
                  </name>
                  <aff><institution>Leeds Institute of Cardiovascular and Metabolic Medicine, University of
Leeds</institution>, <addr-line>6 Clarendon Way, LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9895-9356</contrib-id>
                  <name>
                    <surname>Nadarajah</surname>
                    <given-names>Ramesh</given-names>
                  </name>
                  <aff><institution>Leeds Institute of Cardiovascular and Metabolic Medicine, University of
Leeds</institution>, <addr-line>6 Clarendon Way, LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Department of Cardiology, Leeds Teaching Hospitals NHS Trust</institution>,
<addr-line>LS1 3EX Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8149-3449</contrib-id>
                  <name>
                    <surname>Hurdus</surname>
                    <given-names>Ben</given-names>
                  </name>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Aktaa</surname>
                    <given-names>Suleman</given-names>
                  </name>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Department of Cardiology, Leeds Teaching Hospitals NHS Trust</institution>,
<addr-line>LS1 3EX Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Haris</surname>
                    <given-names>Mohammad</given-names>
                  </name>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Department of Cardiology, Leeds Teaching Hospitals NHS Trust</institution>,
<addr-line>LS1 3EX Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Keeley</surname>
                    <given-names>Adam</given-names>
                  </name>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>West</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <aff><institution>Leeds Institute of Health Sciences, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hall</surname>
                    <given-names>Alistair</given-names>
                  </name>
                  <aff><institution>Leeds Institute of Cardiovascular and Metabolic Medicine, University of
Leeds</institution>, <addr-line>6 Clarendon Way, LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Department of Cardiology, Leeds Teaching Hospitals NHS Trust</institution>,
<addr-line>LS1 3EX Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0013-0660</contrib-id>
                  <name>
                    <surname>Soloveva</surname>
                    <given-names>Anzhela</given-names>
                  </name>
                  <aff><institution>Department of Cardiology, Almazov National Medical Research
Centre</institution>, <addr-line>2 Akkuratova street, Saint Petersburg
197341</addr-line>, <country country="RU">Russian</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6211-1625</contrib-id>
                  <name>
                    <surname>Norman</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <aff><institution>School of Geography, University of Leeds</institution>, <addr-line>LS2 9JT
Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gale</surname>
                    <given-names>Chris P</given-names>
                  </name>
                  <aff><institution>Leeds Institute of Cardiovascular and Metabolic Medicine, University of
Leeds</institution>, <addr-line>6 Clarendon Way, LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Leeds Institute for Data Analytics, University of Leeds</institution>,
<addr-line>LS2 9JT Leeds</addr-line>, <country country="GB">UK</country></aff>
                  <aff><institution>Department of Cardiology, Leeds Teaching Hospitals NHS Trust</institution>,
<addr-line>LS1 3EX Leeds</addr-line>, <country country="GB">UK</country></aff>
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><bold>Corresponding author.</bold> Tel: +44 (0)113 343 0214, Email: <email>T.munyombwe@leeds.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2023-07-14">
                <day>14</day>
                <month>7</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>14</day>
                <month>7</month>
                <year>2023</year>
              </pub-date>
              <volume>9</volume>
              <issue>5</issue>
              <fpage>442</fpage>
              <lpage>446</lpage>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>6</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>13</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
                <date date-type="corrected-typeset">
                  <day>24</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of
the European Society of Cardiology.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
reuse, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="qcad040.pdf"/>
              <related-article related-article-type="correction-forward" ext-link-type="doi" id="qcad066" xlink:href="10.1093/ehjqcco/qcad066"/>
              <abstract>
                <title>Abstract</title>
                <sec id="abs1">
                  <title>Aims</title>
                  <p>The Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)
longitudinal cohort study aims to investigate health trajectories of individuals
following hospitalization for myocardial infarction (MI).</p>
                </sec>
                <sec id="abs2">
                  <title>Methods and results</title>
                  <p>EMMACE is a linked multicentre prospective cohort study of 14 899 patients with MI
admitted to 77 hospitals in England who participated in the EMMACE-3 and -4 studies
between 1st November 2011 and 24th June 2015. Long-term follow-up of the EMMACE cohorts
was conducted through the EMMACE-XL (27th September 2020 to 31st March 2022) and
EMMACE-XXL (1st July 2021 to 1st July 2023) studies. EMMACE collected individual
participant data for health-related quality of life (HRQoL) measured by three-level
EuroQol five-dimension and visual analogy scale at admission, 1 month, 6 months, 12
months, and 10 years follow-up, as well as medications, medication adherence, beliefs
about medicines, Satisfaction with Information about Medicines Scale, and illness
perceptions. Participant data were deterministically linked to the Myocardial Infarction
National Audit Project (MINAP) for information on baseline treatments and comorbidities,
Hospital Episode Statistics Admitted Patient Care (for cause-specific hospitalization
data), and the Office for National Statistics (for mortality data) up to 2020.</p>
                </sec>
                <sec id="abs3">
                  <title>Conclusion</title>
                  <p>EMMACE is a nationwide prospective cohort that will provide unique insights into fatal
and non-fatal outcomes, medication adherence, and HRQoL following MI.</p>
                  <p>Trial registration: <ext-link xlink:href="http://www.ClinicalTrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link> NCT01808027 and NCT01819103</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="keywords">
                <kwd>Myocardial infarction</kwd>
                <kwd>Outcomes</kwd>
                <kwd>Hospitalizations</kwd>
                <kwd>Medications</kwd>
                <kwd>Health-related quality of life</kwd>
                <kwd>Cohort</kwd>
                <kwd>Electronic health records</kwd>
                <kwd>Longitudinal data</kwd>
              </kwd-group>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>British Heart Foundation</institution>
                      <institution-id institution-id-type="DOI">10.13039/501100000274</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>PG/19/54/34511</award-id>
                  <award-id>PG/19/54/34511</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute for Health Research</institution>
                      <institution-id institution-id-type="DOI">10.13039/501100000272</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>NIHR/CS/009/004</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Wellcome Trust</institution>
                      <institution-id institution-id-type="DOI">10.13039/100010269</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>206470/Z/17/Z</award-id>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="5"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <boxed-text position="float">
              <sec id="box1">
                <title>Key learning points</title>
                <p>What is already known</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Health-related quality of life (HRQoL) is a key outcome in cardiovascular diseases.
Researchers have focused mostly on objective measures of health, such as mortality and
morbidity, but HRQoL may impact negatively on patient outcomes.</p>
                  </list-item>
                </list>
                <p>What this study adds</p>
                <list list-type="bullet">
                  <list-item>
                    <p>This is the largest nationwide patient-level cohort to date that provides a holistic
view on health states of myocardial infarction (MI) survivors capturing HRQoL and
clinical outcome trends up to 10 years following hospitalization with MI. The use of a
longitudinal study design allows the capture of temporal trends in changes of HRQoL
over time and associations with patient outcomes.</p>
                  </list-item>
                  <list-item>
                    <p>This cohort profile data can be used to determine the associations of HRQoL with
fatal and non-fatal outcomes following MI identifying precisely in whom worse (or
better) outcomes may occur to permit the design and testing of novel interventions to
reduce premature death from MI and its complications.</p>
                  </list-item>
                </list>
              </sec>
            </boxed-text>
            <sec sec-type="intro" id="sec2">
              <title>Introduction</title>
              <p>Cardiovascular disease is the leading cause of death globally,<sup><xref rid="bib1" ref-type="bibr">1</xref></sup> contributing to a third of all deaths and reduced quality of
life.<sup><xref rid="bib2" ref-type="bibr">2</xref></sup> Despite a substantial decline
in mortality rates from cardiovascular disease,<sup><xref rid="bib3" ref-type="bibr">3–5</xref></sup> myocardial infarction (MI) remains unnecessarily
common and, in addition to its death toll and economic burden, is associated with a legacy
of recurrent cardiovascular events, including heart failure, cerebrovascular disease, and
MI.<sup><xref rid="bib2" ref-type="bibr">2</xref>,<xref rid="bib6" ref-type="bibr">6</xref></sup></p>
              <p>Information about the health outcomes of people with MI is required to determine individual
health needs, enable earlier detection and treatment of new onset disease, and inform health
service planning. However, there is a limited literature about health outcomes of people
with MI that is nationally representative, includes patient survey data as well as
information systematically collected through electronic health records (EHRs), and extends
many years from the index admission MI. In some geographies, fatal and non-fatal
cardiovascular events after MI have now reached a plateau, yet remain elevated beyond the
first year.<sup><xref rid="bib7" ref-type="bibr">7–9</xref></sup> This suggests a
need for prolonged surveillance of individuals with MI and a refreshed perspective on the
outcomes from MI and their management. This paper provides a cohort profile of the
Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal
cohort study containing long-term survey and EHRs follow-up data for individuals with MI
across 77 hospitals in England. The EMMACE-3 and -4 studies<sup><xref rid="bib10" ref-type="bibr">10</xref></sup> and the EMMACE-XL and EMMACE-XXL follow-up studies were
designed to collect individual participant data about a wide range of clinical outcomes
following admission with MI.</p>
              <sec id="sec2-1">
                <title>Aim of the EMMACE longitudinal cohort</title>
                <p>The aim of the EMMACE longitudinal cohort is to collect and study longitudinal health
outcomes in individuals admitted with MI, providing unique insights into patient health
trajectories after MI, including healthcare utilization, health-related (HRQoL), and how
they may change over time.</p>
              </sec>
              <sec id="sec2-2">
                <title>Quality-of-care interventions</title>
                <p>The EMMACE longitudinal cohort builds on the successes of EMMACE-1 and -2, which were
used for translational and cardiovascular outcomes research.<sup><xref rid="bib11" ref-type="bibr">11–21</xref></sup> Individual patient data were collected across healthcare
utilization, HRQoL, and how they changed over time. As the registry aims to capture
real-world outcomes for patients who had experienced an MI, management and/or treatment
management strategies were not pre-specified by the study protocol.</p>
              </sec>
              <sec id="sec2-3">
                <title>Study setting</title>
                <p>A total of 77 National Health Service (NHS) hospitals in England (<xref rid="fig1" ref-type="fig"><italic toggle="yes">Figure 1</italic></xref>) participated in the study, which comprises
data from two sequential recruiting cohorts—EMMACE-3 and EMMACE-4.</p>
                <fig position="float" id="fig1">
                  <label>Figure 1</label>
                  <caption>
                    <p>Regional maps of English National Health Service hospitals and patients participating
in the Evaluation of the Methods and Management of Acute Events [EMMACE]-3 and 4.</p>
                  </caption>
                  <graphic xlink:href="qcad040fig1" position="float"/>
                </fig>
              </sec>
              <sec id="sec2-4">
                <title>Populations and consent</title>
                <p>EMMACE-3 (<italic toggle="yes">n</italic> = 5556) participants were recruited between 1st November
2011 and 17th September 2013 and EMMACE-4 (<italic toggle="yes">n</italic> = 9343) participants were
recruited between 1st October 2013 and 24th June 2015. Long-term follow-up of the EMMACE
cohorts was conducted through the EMMACE-XL (27th September 2020 to 31st March 2022) and
EMMACE-XXL (1st July 2021 to 1st July 2023).</p>
                <p>Participants consented to enter the EMMACE-3 and -4 studies and for their data to be
linked to other datasets and shared. The EMMACE-3 and -4 studies were given ethics
approval by the Leeds (West) Research Ethics Committee (REC reference: 10/H131374,
13/YH/0277, and 12/WM/0431). The EMMACE-XL and EMMACE-XXL studies were granted ethics
approval by the London Bridge Research Ethics Committee (EMMACE-XL, 20/PR/0104) and by
London-Hampstead Research ethics committee (EMMACE-XXL, 21/PR/0810). Permissions for the
linked Hospital Episode Statistics Admitted Patient Care (HES APC) data and ONS mortality
data were obtained through NHS Digital (DARS-NIC-332338-X1N2G-v0.9).</p>
              </sec>
              <sec id="sec2-5">
                <title>Start points</title>
                <p>The EMMACE studies included patients aged 18 years or older who had been admitted with an
acute coronary syndrome at one of the participating hospitals. Patients at a terminal
stage of any illness, and those for whom follow-up would be inappropriate or impractical
(e.g. patients requiring emergency treatment), were excluded from the study.</p>
              </sec>
              <sec id="sec2-6">
                <title>Baseline and follow-up data</title>
                <p>Baseline data included patient demographics and socioeconomic status, patient-reported
data at the time of admission with MI concerning HRQoL (the three-level EuroQol
five-dimension [EQ-5D-3L],<sup><xref rid="bib22" ref-type="bibr">22</xref></sup> EQ visual
analogue scale [EQ-VAS]), treatments, medication beliefs questionnaire,<sup><xref rid="bib23" ref-type="bibr">23</xref></sup> Single Question Medicine Adherence,
Satisfaction with Information about Medicines Scale [SIMS],<sup><xref rid="bib24" ref-type="bibr">24</xref></sup> Care Quality Commission Pickering Inpatient
questionnaire,<sup><xref rid="bib25" ref-type="bibr">25</xref></sup> and Brief Illness
Perception.<sup><xref rid="bib26" ref-type="bibr">26</xref></sup> Baseline
co-morbidities and quality-of-care data were obtained from the Myocardial Infarction
National Audit Project (MINAP) registry.<sup><xref rid="bib27" ref-type="bibr">27</xref></sup></p>
                <p>Follow-up of HRQoL measured by EQ-5D-3L and EQ-VAS was recorded at 1 month, 6 months, and
12 months. At 10 years, through the EMMACE-XL study (2020–21), the EMMACE cohort
participants were contacted and consented to complete a further quality-of-life
questionnaire (EQ-5D-3L, EQ-VAS), supply their current medication data, and answer a
question relating to their perceived adherence to their current medication as well as to
answer lifestyle questions about their smoking habits. An additional follow-up of the
EMMACE cohort was through the EMMACE- XXL(2021–22) study that collected further
quality-of-life data (EQ-5D-3L, EQ-VAS), information about frailty (using the Program of
Research on Integration of Services for the Maintenance of Autonomy [PRISMA-7] frailty
questionnaire),<sup><xref rid="bib28" ref-type="bibr">28</xref></sup> and the Single
Question Medicine Adherence tool. Details of the EMMACE data flow are shown in <xref rid="fig2" ref-type="fig"><italic toggle="yes">Figure 2</italic></xref>, and variables in the EMMACE
dataset are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary
material online, <italic toggle="yes">Table S1</italic></xref>.</p>
                <fig position="float" id="fig2">
                  <label>Figure 2</label>
                  <caption>
                    <p>The EMMACE longitudinal cohort data flow and linkages.</p>
                  </caption>
                  <graphic xlink:href="qcad040fig2" position="float"/>
                </fig>
              </sec>
              <sec id="sec2-7">
                <title>Data quality and linkages</title>
                <p>Consented EMMACE-3 and -4 participants (<italic toggle="yes">n</italic> = 14 899) were linked to the
MINAP registry<sup><xref rid="bib27" ref-type="bibr">27</xref></sup> with a further
deterministic linkage with HES-APC<sup><xref rid="bib29" ref-type="bibr">29</xref></sup>
data and the Office for National Statistics for the years 2010/11 to 2020/21 by NHS
Digital acting as the trusted third party (DARS-NIC-332338-X1N2G-v0.9). Each participant's
NHS number, date of birth, and sex along with their EMMACE study identification number was
securely transmitted to NHS Digital whereby returned data included (for patients with
prior and/or subsequent hospitalizations) corresponding HES records, cause of death, and
date of death for patients who have died. NHS Digital publishes how their databases are
regularly checked to ensure accuracy of the recorded data, and their methods of data
cleaning and quality assurance.<sup><xref rid="bib30" ref-type="bibr">30</xref></sup>
Details of the EMMACE data flow are shown in <xref rid="fig2" ref-type="fig"><italic toggle="yes">Figure 2</italic></xref>.</p>
              </sec>
              <sec id="sec2-8">
                <title>Data capture and storage</title>
                <p>The data are considered highly confidential as they contain identifiable patient-level
data linked with EHRs, clinical management data and their storage and sharing abide by the
University of Leeds data protection and sharing policies. Data are stored in the Leeds
Analytics Secure Environment for Research (LASER) within the University of Leeds. LASER is
a Leeds Institute for Data Analytics purpose-built cloud-based platform for hosting
sensitive data compliant with ISO 27001 standards and the NHS Data security and protection
toolkit. Pseudonymized data are accessible for analysis with approval from the local data
controller (CPG) in a dedicated secure LASER Virtual Research Environment. All individuals
with access to these data are required to undergo the University of Leeds information
security training and to sign an information security policy before accessing the data.
The University of Leeds Information Security Policy is implemented and drawn up in line
with ISO 27 001.</p>
              </sec>
              <sec id="sec2-9">
                <title>Access to data</title>
                <p>Access to the EMMACE longitudinal cohort data may be requested by contacting the Chief
Investigator (CPG).</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec3">
              <title>Conclusion</title>
              <p>The EMMACE longitudinal cohort is a nationwide individual participant-level database that
provides a holistic view of the states of health of people with MI, capturing HRQoL,
medications, all hospitalized events, and all deaths during 10 years of follow-up. The
real-world origin and robustness of the data sources provide a strong basis for the
generalizability of the study results, which can be translated into novel post-MI healthcare
system goals. Phenotyping MI survivors based on longitudinal changes in HRQoL and subsequent
outcomes may allow healthcare providers to identify high-risk group of patients who may
benefit from timely targeted interventions to achieve sustained improvements in health
status.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="sup1" position="float" content-type="local-data">
                <label>qcad040_Supplemental_File</label>
                <media xlink:href="qcad040_supplemental_file.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="ack1">
              <title>Acknowledgements</title>
              <p>We gratefully acknowledge the contributions from all hospitals, principal investigators,
healthcare professionals, research staff, and patients who participated in the EMMACE study.
We also thank Richard Gillott (Leeds Teaching Hospitals NHS Trust IT support), Clare Forest
(EMMACE-3 and -4 project coordinator), Adam Keely (IT support), Sean Tuck (IT support),
Claire Forrest (cardiology research coordinator), Catherine Reynolds (EMMACE-XL project
manager), and Gerard Oliver, who was involved as a patient advisor in designing the EMMACE
studies.</p>
            </ack>
            <sec id="sec4">
              <sec id="sec4-1">
                <title>Author contributions</title>
                <p>C.P.G. and A.S.H. contributed to the conception of the research. C.P.G., T.M., M.H.,
A.S.H., R.W., and B.H. contributed to funding acquisition. T.M., C.R., M.H., B.H., C.F.,
T.B.D., A.K., and S.T. were involved in NHS Digital data acquisition and management.
T.B.D., C.R., B.H., and T.M. were involved in ethics applications. P.N. produced the map
of participants by hospital. A.S. produced Figure 2. T.M. drafted the first version of
this manuscript, all co-authors made critical revisions and provided intellectual content
to the manuscript, approved the final version to be published, and agreed to be
accountable for all aspects of the work. C.P.G. and T.M. are the guarantors for this
study.</p>
              </sec>
            </sec>
            <sec id="sec5">
              <sec id="sec5-1">
                <title>Funding</title>
                <p>This work is funded by British Heart Foundation Project Grant No. PG/19/54/34511. C.P.G.
was funded by the National Institute for Health Research (NIHR/CS/009/004). T.B.D. is
funded by the British Heart Foundation (PG/19/54/34511). M.H. is funded by the Wellcome
Trust (206470/Z/17/Z).</p>
              </sec>
            </sec>
            <sec sec-type="COI-statement" id="sec6">
              <title>Conflict of interest</title>
              <p>C.P.G. reports grants from the British Heart Foundation, National Institute for Health
Research, Horizon 2020, Abbott Diabetes, and Bristol Myers Squibband personal fees from
AstraZeneca, Bayer, Bristol Myers Squibb, Boehrinher Ingleheim, Chiesi, CYTE Global, Daiichi
Sankyo, Menarini, Novartis, Raisio Group, Wondr Medical, and Zydus outside the submitted
work. The other authors declare that they have no competing interests.</p>
            </sec>
            <sec sec-type="data-availability" id="sec7-1">
              <title>Data availability</title>
              <p>The data underlying this article will be shared on reasonable request to the Chief
Investigator (C.P.G.).</p>
            </sec>
            <ref-list id="ref1">
              <title>References</title>
              <ref id="bib1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vos</surname>  <given-names>T</given-names></string-name>,
<string-name><surname>Abajobir</surname>
 <given-names>AA</given-names></string-name>, <string-name><surname>Abate</surname>
 <given-names>KH</given-names></string-name></person-group>. <article-title>Global,
regional, and national incidence, prevalence, and years lived with disability for 328
diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global
Burden of Disease Study 2016</article-title>. <source>Lancet North Am Ed</source>
 <year>2017</year>;<volume>390</volume>(10100):<fpage>1211</fpage>–<lpage>1259</lpage>.</mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mensah</surname>  <given-names>GA</given-names></string-name>,
<string-name><surname>Roth</surname>  <given-names>GA</given-names></string-name>,
<string-name><surname>Fuster</surname>
 <given-names>V.</given-names></string-name></person-group>  <article-title>The global
burden of cardiovascular diseases and risk factors: 2020 and beyond</article-title>.
<source>J Am Coll Cardiol</source>
 <year>2019</year>;<volume>74</volume>(20):<fpage>2529</fpage>–<lpage>2532</lpage>.<pub-id pub-id-type="pmid">31727292</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gale</surname>  <given-names>C</given-names></string-name>,
<string-name><surname>Cattle</surname>  <given-names>B</given-names></string-name>,
<string-name><surname>Woolston</surname>
 <given-names>A</given-names></string-name>, <string-name><surname>Baxter</surname>
 <given-names>PD</given-names></string-name>, <string-name><surname>West</surname>
 <given-names>TH</given-names></string-name>, <string-name><surname>Simms</surname>
 <given-names>AD</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>Resolving inequalities in care? Reduced mortality in the elderly after
acute coronary syndromes. The Myocardial Ischaemia National Audit Project
2003–2010</article-title>. <source>Eur Heart J</source>
 <year>2011</year>;<volume>33</volume>(5):<fpage>630</fpage>–<lpage>639</lpage>.<pub-id pub-id-type="pmid">22009446</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smolina</surname>  <given-names>K</given-names></string-name>,
<string-name><surname>Wright</surname>  <given-names>F</given-names></string-name>,
<string-name><surname>Rayner</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Goldacre</surname>
 <given-names>MJ</given-names></string-name></person-group>.
<article-title>Determinants of the decline in mortality from acute myocardial infarction
in England between 2002 and 2010: linked national database study</article-title>.
<source>BMJ</source>
 <year>2012</year>;<volume>344</volume>:<fpage>d8059</fpage><pub-id pub-id-type="pmid">22279113</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gale</surname>  <given-names>C</given-names></string-name>,
<string-name><surname>Cattle</surname>  <given-names>B</given-names></string-name>,
<string-name><surname>Baxter</surname>  <given-names>P</given-names></string-name>,
<string-name><surname>Greenwood</surname>
 <given-names>DC</given-names></string-name>, <string-name><surname>Simms</surname>
 <given-names>AD</given-names></string-name>,
<string-name><surname>Deanfield</surname>
 <given-names>J</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>Age-dependent inequalities in improvements in mortality occur early
after acute myocardial infarction in 478,242 patients in the Myocardial Ischaemia
National Audit Project (MINAP) registry</article-title>. <source>Int J Cardiol</source>
 <year>2013</year>;<volume>168</volume>(2):<fpage>881</fpage>–<lpage>887</lpage>.<pub-id pub-id-type="pmid">23177996</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heidenreich</surname>  <given-names>PA</given-names></string-name>,
<string-name><surname>Trogdon</surname>
 <given-names>JG</given-names></string-name>, <string-name><surname>Khavjou</surname>
 <given-names>OA</given-names></string-name>, <string-name><surname>Butler</surname>
 <given-names>J</given-names></string-name>, <string-name><surname>Dracup</surname>
 <given-names>K</given-names></string-name>,
<string-name><surname>Ezekowitz</surname>
 <given-names>MD</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>Forecasting the future of cardiovascular disease in the United States: a
policy statement from the American Heart Association</article-title>.
<source>Circulation</source>  <year>2011</year>;<volume>123</volume>(8):
<fpage>933</fpage>–<lpage>944</lpage>.<pub-id pub-id-type="pmid">21262990</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Puymirat</surname>  <given-names>E</given-names></string-name>,
<string-name><surname>Simon</surname>  <given-names>T</given-names></string-name>,
<string-name><surname>Cayla</surname>  <given-names>G</given-names></string-name>,
<string-name><surname>Cottin</surname>  <given-names>Y</given-names></string-name>,
<string-name><surname>Elbaz</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Coste</surname>  <given-names>P</given-names></string-name>
 <etal>et al.</etal></person-group>  <article-title>Acute myocardial infarction:
changes in patient characteristics, management, and 6-month outcomes over a period of 20
years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation
Myocardial Infarction) 1995 to 2015</article-title>. <source>Circulation</source>
 <year>2017</year>;<volume>136</volume>(20):<fpage>1908</fpage>–<lpage>1919</lpage>.<pub-id pub-id-type="pmid">28844989</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jernberg</surname>  <given-names>T</given-names></string-name>,
<string-name><surname>Hasvold</surname>  <given-names>P</given-names></string-name>,
<string-name><surname>Henriksson</surname>
 <given-names>M</given-names></string-name>, <string-name><surname>Hjelm</surname>
 <given-names>H</given-names></string-name>,
<string-name><surname>Thuresson</surname>
 <given-names>M</given-names></string-name>, <string-name><surname>Janzon</surname>
 <given-names>M</given-names></string-name></person-group>.
<article-title>Cardiovascular risk in post-myocardial infarction patients: nationwide
real world data demonstrate the importance of a long-term perspective</article-title>.
<source>Eur Heart J</source>
 <year>2015</year>;<volume>36</volume>(19):<fpage>1163</fpage>–<lpage>1170</lpage>.<pub-id pub-id-type="pmid">25586123</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lüscher</surname>  <given-names>TF.</given-names></string-name></person-group>  <article-title>Frontiers of acute coronary syndromes: primary PCI time
window, 15-year outcomes, bleeding and MINOCA</article-title>. <source>Eur Heart
J</source>
 <year>2020</year>;<volume>41</volume>(7):<fpage>805</fpage>–<lpage>809</lpage>.<pub-id pub-id-type="pmid">33216912</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alabas</surname>  <given-names>O</given-names></string-name>,
<string-name><surname>West</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Gillott</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Khatib</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Hall</surname>  <given-names>AS</given-names></string-name>,
<string-name><surname>Gale</surname>  <given-names>CP</given-names></string-name>
 <etal>et al.</etal></person-group>  <article-title>Evaluation of the Methods and
Management of Acute Coronary Events (EMMACE)-3: protocol for a longitudinal
study</article-title>. <source>BMJ Open</source>
 <year>2015</year>;<volume>5</volume>(6):<fpage>e006256</fpage>.</mixed-citation>
              </ref>
              <ref id="bib11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewinter</surname>  <given-names>C</given-names></string-name>,
<string-name><surname>Bland</surname>  <given-names>JM</given-names></string-name>,
<string-name><surname>Crouch</surname>  <given-names>S</given-names></string-name>,
<string-name><surname>Doherty</surname>  <given-names>P</given-names></string-name>,
<string-name><surname>Lewin</surname>  <given-names>RJ</given-names></string-name>,
<string-name><surname>Køber</surname>  <given-names>L</given-names></string-name>
 <etal>et al.</etal></person-group>  <article-title>The effect of referral for cardiac
rehabilitation on survival following acute myocardial infarction: a comparison survival
in two cohorts collected in 1995 and 2003</article-title>. <source>Eur J Prev
Cardiol</source>
 <year>2014</year>;<volume>21</volume>(2):<fpage>163</fpage>–<lpage>171</lpage>.<pub-id pub-id-type="pmid">23180866</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewinter</surname>  <given-names>C</given-names></string-name>,
<string-name><surname>Bland</surname>  <given-names>JM</given-names></string-name>,
<string-name><surname>Crouch</surname>  <given-names>S</given-names></string-name>,
<string-name><surname>Cleland</surname>
 <given-names>JGF</given-names></string-name>, <string-name><surname>Doherty</surname>
 <given-names>P</given-names></string-name>,
<string-name><surname>LeWinter</surname>
 <given-names>MM</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>Impact of aspirin and statins on long-term survival in patients
hospitalized with acute myocardial infarction complicated by heart failure: an analysis
of 1706 patients</article-title>. <source>Eur J Heart Fail</source>
 <year>2014</year>;<volume>16</volume>(1):<fpage>95</fpage>–<lpage>102</lpage>.<pub-id pub-id-type="pmid">24453098</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lown</surname>  <given-names>MT</given-names></string-name>,
<string-name><surname>Munyombwe</surname>
 <given-names>T</given-names></string-name>, <string-name><surname>Harrison</surname>
 <given-names>W</given-names></string-name>, <string-name><surname>West</surname>
 <given-names>RM</given-names></string-name>, <string-name><surname>Hall</surname>
 <given-names>CA</given-names></string-name>,
<string-name><surname>Morrell</surname>  <given-names>C</given-names></string-name>
 <etal>et al.</etal></person-group>  <article-title>Association of frontal QRS-T
angle—age risk score on admission electrocardiogram with mortality in patients admitted
with an acute coronary syndrome</article-title>. <source>Am J Cardiol</source>
 <year>2012</year>;<volume>109</volume>(3):<fpage>307</fpage>–<lpage>313</lpage>.<pub-id pub-id-type="pmid">22071208</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gale</surname>  <given-names>CP</given-names></string-name>,
<string-name><surname>Metcalfe</surname>
 <given-names>E</given-names></string-name>, <string-name><surname>West</surname>
 <given-names>RM</given-names></string-name>, <string-name><surname>Das</surname>
 <given-names>R</given-names></string-name>,
<string-name><surname>Kilcullen</surname>
 <given-names>N</given-names></string-name>, <string-name><surname>Morrell</surname>
 <given-names>C</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>An assessment of the concentration-related prognostic value of cardiac
troponin I following acute coronary syndrome</article-title>. <source>Am J
Cardiol</source>
 <year>2011</year>;<volume>108</volume>(9):<fpage>1259</fpage>–<lpage>1265</lpage>.<pub-id pub-id-type="pmid">21871592</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cubbon</surname>  <given-names>RM</given-names></string-name>,
<string-name><surname>Wheatcroft</surname>
 <given-names>SB</given-names></string-name>, <string-name><surname>Grant</surname>
 <given-names>PJ</given-names></string-name>, <string-name><surname>Gale</surname>
 <given-names>CP</given-names></string-name>, <string-name><surname>Barth</surname>
 <given-names>JH</given-names></string-name>,
<string-name><surname>Sapsford</surname>
 <given-names>RJ</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>Temporal trends in mortality of patients with diabetes mellitus
suffering acute myocardial infarction: a comparison of over 3000 patients between 1995
and 2003</article-title>. <source>Eur Heart J</source>
 <year>2007</year>;<volume>28</volume>(5):<fpage>540</fpage>–<lpage>545</lpage>.<pub-id pub-id-type="pmid">17289742</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cubbon</surname>  <given-names>RM</given-names></string-name>,
<string-name><surname>Adams</surname>  <given-names>B</given-names></string-name>,
<string-name><surname>Rajwani</surname>  <given-names>A</given-names></string-name>,
<string-name><surname>Mercer</surname>  <given-names>BN</given-names></string-name>,
<string-name><surname>Patel</surname>  <given-names>PA</given-names></string-name>,
<string-name><surname>Gherardi</surname>  <given-names>G</given-names></string-name>
 <etal>et al.</etal></person-group>  <article-title>Diabetes mellitus is associated
with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic
aetiology</article-title>. <source>Diab Vasc Dis Res</source>
 <year>2013</year>;<volume>10</volume>(4):<fpage>330</fpage>–<lpage>336</lpage>.<pub-id pub-id-type="pmid">23349368</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Das</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Dorsch</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Lawrance</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Kilcullen</surname>
 <given-names>N</given-names></string-name>,
<string-name><surname>Sapsford</surname>
 <given-names>RJ</given-names></string-name>, <string-name><surname>Robinson</surname>
 <given-names>MB</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>External validation, extension and recalibration of Braunwald's simple
risk index in a community-based cohort of patients with both STEMI and
NSTEMI</article-title>. <source>Int J Cardiol</source>
 <year>2006</year>;<volume>107</volume>(3):<fpage>327</fpage>–<lpage>332</lpage>.<pub-id pub-id-type="pmid">15923049</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Das</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Kilcullen</surname>
 <given-names>N</given-names></string-name>, <string-name><surname>Morrell</surname>
 <given-names>C</given-names></string-name>,
<string-name><surname>Robinson</surname>
 <given-names>MB</given-names></string-name>, <string-name><surname>Barth</surname>
 <given-names>JH</given-names></string-name>, <string-name><surname>Hall</surname>
 <given-names>AS</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>The British Cardiac Society Working Group definition of myocardial
infarction: implications for practice</article-title>. <source>Heart</source>
 <year>2006</year>;<volume>92</volume>(1):<fpage>21</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">15831600</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dorsch</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Lawrance</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Sapsford</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Oldham</surname>
 <given-names>J</given-names></string-name>,
<string-name><surname>Greenwood</surname>
 <given-names>D</given-names></string-name>, <string-name><surname>Jackson</surname>
 <given-names>B</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>A simple benchmark for evaluating quality of care of patients following
acute myocardial infarction</article-title>. <source>Heart</source>
 <year>2001</year>;<volume>86</volume>(2):<fpage>150</fpage>–<lpage>154</lpage>.<pub-id pub-id-type="pmid">11454829</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dorsch</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Lawrance</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Sapsford</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Durham</surname>
 <given-names>N</given-names></string-name>, <string-name><surname>Oldham</surname>
 <given-names>J</given-names></string-name>,
<string-name><surname>Greenwood</surname>
 <given-names>DC</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>Poor prognosis of patients presenting with symptomatic myocardial
infarction but without chest pain</article-title>. <source>Heart</source>
 <year>2001</year>;<volume>86</volume>(5):<fpage>494</fpage>–<lpage>498</lpage>.<pub-id pub-id-type="pmid">11602537</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dorsch</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Lawrance</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Sapsford</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Durham</surname>
 <given-names>N</given-names></string-name>, <string-name><surname>Das</surname>
 <given-names>R</given-names></string-name>, <string-name><surname>Jackson</surname>
 <given-names>BM</given-names></string-name>  <etal>et al.</etal></person-group>
 <article-title>An evaluation of the relationship between specialist training in
cardiology and implementation of evidence-based care of patients following acute
myocardial infarction</article-title>. <source>Int J Cardiol</source>
 <year>2004</year>;<volume>96</volume>(3):<fpage>335</fpage>–<lpage>340</lpage>.<pub-id pub-id-type="pmid">15301884</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib22">
                <label>22.</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Kind</surname>  <given-names>P</given-names></string-name>,
<string-name><surname>Brooks</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Rabin</surname>
 <given-names>R.</given-names></string-name></person-group>  <source>EQ-5D concepts and
method: A Developmental History.</source>  <publisher-loc>Dordrecht</publisher-loc>:
<publisher-name>Springer</publisher-name>; <year>2005</year>.</mixed-citation>
              </ref>
              <ref id="bib23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horne</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Weinman</surname>
 <given-names>J.</given-names></string-name></person-group>  <article-title>Patients'
beliefs about prescribed medicines and their role in adherence to treatment in chronic
physical illness</article-title>. <source>J Psychosom Res</source>
 <year>1999</year>;<volume>47</volume>(6):<fpage>555</fpage>–<lpage>567</lpage>.<pub-id pub-id-type="pmid">10661603</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horne</surname>  <given-names>R</given-names></string-name>,
<string-name><surname>Hankins</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Jenkins</surname>
 <given-names>R.</given-names></string-name></person-group>  <article-title>The
Satisfaction with information about Medicines Scale (SIMS): a new measurement tool for
audit and research</article-title>. <source>BMJ Qual Saf</source>
 <year>2001</year>;<volume>10</volume>(3):<fpage>135</fpage>–<lpage>140</lpage>.</mixed-citation>
              </ref>
              <ref id="bib25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jenkinson</surname>  <given-names>C</given-names></string-name>,
<string-name><surname>Coulter</surname>  <given-names>A</given-names></string-name>,
<string-name><surname>Bruster</surname>
 <given-names>S.</given-names></string-name></person-group>  <article-title>The Picker
Patient Experience Questionnaire: development and validation using data from in-patient
surveys in five countries</article-title>. <source>Int J Qual Health Care</source>
 <year>2002</year>;<volume>14</volume>(5):<fpage>353</fpage>–<lpage>358</lpage>.<pub-id pub-id-type="pmid">12389801</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Broadbent</surname>  <given-names>E</given-names></string-name>,
<string-name><surname>Petrie</surname>  <given-names>KJ</given-names></string-name>,
<string-name><surname>Main</surname>  <given-names>J</given-names></string-name>,
<string-name><surname>Weinman</surname>
 <given-names>J</given-names></string-name></person-group>. <article-title>The brief
illness perception questionnaire</article-title>. <source>J Psychosom Res</source>
 <year>2006</year>;<volume>60</volume>(6):<fpage>631</fpage>–<lpage>637</lpage>.<pub-id pub-id-type="pmid">16731240</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilkinson</surname>  <given-names>C</given-names></string-name>,
<string-name><surname>Weston</surname>  <given-names>C</given-names></string-name>,
<string-name><surname>Timmis</surname>  <given-names>A</given-names></string-name>,
<string-name><surname>Quinn</surname>  <given-names>T</given-names></string-name>,
<string-name><surname>Keys</surname>  <given-names>A</given-names></string-name>,
<string-name><surname>Gale</surname>
 <given-names>CP</given-names></string-name></person-group>. <article-title>The
Myocardial Ischaemia National Audit Project (MINAP)</article-title>. <source>Eur Heart J
Qual Care Clin Outcomes</source>
 <year>2020</year>;<volume>6</volume>(1):<fpage>19</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">31511861</pub-id>
</mixed-citation>
              </ref>
              <ref id="bib28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffmann</surname>  <given-names>S</given-names></string-name>,
<string-name><surname>Wiben</surname>  <given-names>A</given-names></string-name>,
<string-name><surname>Kruse</surname>  <given-names>M</given-names></string-name>,
<string-name><surname>Jacobsen</surname>
 <given-names>KK</given-names></string-name>, <string-name><surname>Lembeck</surname>
 <given-names>MA</given-names></string-name>, <string-name><surname>Holm</surname>
 <given-names>EA</given-names></string-name></person-group>.
<article-title>Predictive validity of PRISMA-7 as a screening instrument for frailty in
a hospital setting</article-title>. <source>BMJ open</source>
 <year>2020</year>;<volume>10</volume>(10):<fpage>e038768</fpage>.</mixed-citation>
              </ref>
              <ref id="bib29">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Williams</surname>  <given-names>J</given-names></string-name>,
<string-name><surname>Mann</surname>
 <given-names>R.</given-names></string-name></person-group>  <article-title>Hospital
episode statistics: time for clinicians to get involved?</article-title>  <source>Clin
Med</source>
 <year>2002</year>;<volume>2</volume>(1):<fpage>34</fpage>.</mixed-citation>
              </ref>
              <ref id="bib30">
                <label>30.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>NHS Digital</collab></person-group>. <article-title>Provider data quality assurance framework 2023 [updated
17th May 2022]</article-title>. <comment>Available from: <ext-link xlink:href="https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/provider-data-quality-assurance-framework" ext-link-type="uri">https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/provider-data-quality-assurance-framework</ext-link>
accessed 20 April 2023</comment>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
